Skip to main content
ZOONO GROUP LIMITED logo

ZOONO GROUP LIMITED — Investor Relations & Filings

Ticker · ZNO ISIN · AU000000ZNO4 ASX Manufacturing
Open in API
Filings indexed 750 across all filing types
Latest filing 2019-04-16 Interim / Quarterly Rep…
Country AU Australia
Listing ASX ZNO

About ZOONO GROUP LIMITED

https://zoono.com

Zoono Group Limited develops and distributes long-lasting antimicrobial solutions based on a proprietary silane-based technology. This technology creates a molecular layer of protective spikes that mechanically destroy pathogens such as bacteria, viruses, and fungi upon contact. Unlike conventional disinfectants that use chemical poisoning, this physical kill mechanism provides extended protection, remaining active for up to 30 days on surfaces and 24 hours on skin. The company’s product range includes alcohol-free hand sanitizers, surface disinfectants, and specialized treatments for textiles and industrial applications. These solutions are designed for use across diverse sectors, including healthcare, food processing, commercial environments, and consumer retail, offering a non-toxic and durable alternative to traditional hygiene products.

Recent filings

Filing Released Lang Actions
Appendix 4C - quarterly 5 pages 56.6KB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Appendix 4C Quarterly report for entities subject to Listing Rule 4.7B' and contains detailed consolidated cash flow statements for the quarter ended 31 March 2019, including operating, investing, and financing activities. It also includes estimated cash outflows for the next quarter and a compliance statement signed by a director. The content is substantive financial data for a period shorter than a full fiscal year, consistent with a quarterly report. The document is 8754 characters long, which is sufficient to be the report itself rather than an announcement. The presence of detailed financial tables and notes confirms it is a comprehensive interim/quarterly report. Therefore, the correct classification is Interim / Quarterly Report (IR). Q3 2019
2019-04-16 English
Quarterly Activities Report- Zoono Expands Global Operations 6 pages 751.8KB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Zoono Group Limited Quarterly Activities Report; Q3 2019' and provides a detailed overview of the company's activities, sales, new product launches, distribution agreements, testing results, financials for the quarter ended 31 March 2019, and operational updates. It includes substantive financial data such as unaudited sales figures, cash at bank, stock values, and cost details. The document covers a period shorter than a full fiscal year (a quarter) and contains comprehensive financial and operational information rather than just an announcement or summary. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q3 2019
2019-04-16 English
Change in substantial holding 3 pages 975.8KB
Regulatory Filings
2019-04-02 English
Appendix 3B 10 pages 146.3KB
Capital/Financing Update Classification · 100% confidence The document is titled 'Appendix 3B New issue announcement' and contains detailed information about the issuance of new shares, including the number of securities issued, issue price, purpose of the issue, and compliance with ASX listing rules (rules 7.1, 7.1A, etc.). It includes calculations of placement capacity under these rules and a quotation agreement with ASX. The document is a formal announcement related to the issuance of new shares and application for quotation of additional securities on the Australian Securities Exchange (ASX). It is not a financial report, earnings release, or management discussion, but a regulatory announcement about capital raising and share issuance. This fits the definition of a Capital/Financing Update (CAP) filing, which covers updates on company fundraising, financing activities, or capital structure changes.
2019-03-17 English
Zoono Signs Agreement with Midas Pharma GmbH 3 pages 238.8KB
Regulatory Filings Classification · 95% confidence The document is an announcement dated 15th March 2019 from Zoono Group Limited about signing a sales and distribution agreement with Midas Pharma GmbH. It contains no financial data, no regulatory form references, no voting results, no management changes, no earnings or financial report content. It is a corporate announcement about a business partnership agreement. This fits best under a general regulatory announcement category rather than a specific financial report or meeting document. The document length is 4079 characters, which is relatively short and does not contain detailed financial or operational data. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2019-03-14 English
Update on Zoono Proceedings against Stayzon 2 pages 97.5KB
Legal Proceedings Report Classification · 95% confidence The document is an announcement from Zoono Group Limited regarding legal proceedings against Stayzon Retail Ventures Pty Limited, which has been placed into voluntary liquidation. The content focuses on legal updates and the company's intended course of action related to the liquidation and legal claims. There is no financial data, report, or presentation included. The document is a legal proceedings update rather than a financial report or other filing type. Therefore, it fits best under the category of Legal Proceedings Report (LTR). The document length is short and does not indicate it is a report publication announcement or regulatory filing. Hence, the classification is LTR with high confidence.
2019-03-07 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.